Literature DB >> 32437561

Using patient-reported outcomes to improve survivorship care.

Lindsay M Morton1, Betty K Hamilton2.   

Abstract

Entities:  

Year:  2020        PMID： 32437561      PMCID： PMC7243152          DOI： 10.1182/blood.2020005881

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

1.  Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial.

Authors:  Jennifer M Knight; J Douglas Rizzo; Parameswaran Hari; Marcelo C Pasquini; Karen E Giles; Anita D'Souza; Brent R Logan; Mehdi Hamadani; Saurabh Chhabra; Binod Dhakal; Nirav Shah; Deepika Sriram; Mary M Horowitz; Steve W Cole
Journal:  Blood Adv       Date:  2020-02-11

2.  Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful.

Authors:  Bronwen E Shaw; Ruta Brazauskas; Heather R Millard; Rachel Fonstad; Kathryn E Flynn; Amy Abernethy; Jenny Vogel; Charney Petroske; Deborah Mattila; Rebecca Drexler; Stephanie J Lee; Mary M Horowitz; J Douglas Rizzo
Journal:  Cancer       Date:  2017-08-17       Impact factor: 6.860

3.  Patient-reported outcomes in survivors of childhood hematologic malignancies with hematopoietic stem cell transplant.

Authors:  Hsiu-Ju Yen; Hesham M Eissa; Neel S Bhatt; Sujuan Huang; Matthew J Ehrhardt; Nickhill Bhakta; Kirsten K Ness; Kevin R Krull; D Kumar Srivastava; Leslie L Robison; Melissa M Hudson; I-Chan Huang
Journal:  Blood       Date:  2020-05-21       Impact factor: 22.113

4.  Low Socioeconomic Status, Adverse Gene Expression Profiles, and Clinical Outcomes in Hematopoietic Stem Cell Transplant Recipients.

Authors:  Jennifer M Knight; J Douglas Rizzo; Brent R Logan; Tao Wang; Jesusa M G Arevalo; Jeffrey Ma; Steve W Cole
Journal:  Clin Cancer Res       Date:  2015-08-18       Impact factor: 12.531

5.  Social stress up-regulates inflammatory gene expression in the leukocyte transcriptome via β-adrenergic induction of myelopoiesis.

Authors:  Nicole D Powell; Erica K Sloan; Michael T Bailey; Jesusa M G Arevalo; Gregory E Miller; Edith Chen; Michael S Kobor; Brenda F Reader; John F Sheridan; Steven W Cole
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-23       Impact factor: 11.205

6.  Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host disease.

Authors:  Jeanne Palmer; Xiaoyu Chai; Joseph Pidala; Yoshihiro Inamoto; Paul J Martin; Barry Storer; Iskra Pusic; Mary E D Flowers; Mukta Arora; Steven Z Pavletic; Stephanie J Lee
Journal:  Blood       Date:  2015-11-02       Impact factor: 22.113

Review 7.  Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review.

Authors:  Justyna Mierzynska; Claire Piccinin; Madeline Pe; Francesca Martinelli; Carolyn Gotay; Corneel Coens; Murielle Mauer; Alexander Eggermont; Mogens Groenvold; Kristin Bjordal; Jaap Reijneveld; Galina Velikova; Andrew Bottomley
Journal:  Lancet Oncol       Date:  2019-12       Impact factor: 41.316

8.  Patient-reported outcomes and health status associated with chronic graft-versus-host disease.

Authors:  Stephanie J Lee; Lynn Onstad; Eric J Chow; Bronwen E Shaw; Heather S L Jim; Karen L Syrjala; K Scott Baker; Sarah Buckley; Mary E Flowers
Journal:  Haematologica       Date:  2018-06-01       Impact factor: 9.941
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.